Kvien TK - Search Results

1

HLA-DQ2 is associated with anti-drug antibody formation to infliximab in patients with immune-mediated inflammatory diseases.

Brun MK, Bjørlykke KH, Viken MK, Stenvik GE, Klaasen RA, Gehin JE, Warren DJ, Sexton J, Sandanger Ø, Kvien TK, Mørk C, Haavardsholm EA, Jahnsen J, Goll GL, Lie BA, Bolstad N, Jørgensen KK, Syversen SW. Brun MK, et al. Among authors: kvien tk. J Intern Med. 2023 May;293(5):648-655. doi: 10.1111/joim.13616. Epub 2023 Feb 26. J Intern Med. 2023. PMID: 36843323

2

Course and predictors of work productivity in gout - results from the NOR-Gout longitudinal 2-year treat-to-target study.

Uhlig T, Karoliussen LF, Sexton J, Provan SA, Kvien TK, Haavardsholm EA, Hammer HB. Uhlig T, et al. Among authors: kvien tk. Rheumatology (Oxford). 2023 Dec 1;62(12):3886-3892. doi: 10.1093/rheumatology/kead124. Rheumatology (Oxford). 2023. PMID: 36943375 Free PMC article.

3

Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD).

Mielnik P, Sexton J, Fagerli KM, Bakland G, Hu Y, Kristianslund EK, Hoff M, Wierød A, Kvien TK. Mielnik P, et al. Among authors: kvien tk. Rheumatol Adv Pract. 2023 Jun 16;7(2):rkad053. doi: 10.1093/rap/rkad053. eCollection 2023. Rheumatol Adv Pract. 2023. PMID: 37431434 Free PMC article.

4

Associations between pain sensitization and measures of physical function in people with hand osteoarthritis: Results from the Nor-Hand study.

Gløersen M, Steen Pettersen P, Neogi T, Sexton J, Kvien TK, Hammer HB, Haugen IK. Gløersen M, et al. Among authors: kvien tk. Osteoarthritis Cartilage. 2023 Oct;31(10):1388-1395. doi: 10.1016/j.joca.2023.07.005. Epub 2023 Jul 24. Osteoarthritis Cartilage. 2023. PMID: 37495183 Free article.

5

Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases.

Jyssum I, Gehin JE, Sexton J, Kristianslund EK, Hu Y, Warren DJ, Kvien TK, Haavardsholm EA, Syversen SW, Bolstad N, Goll GL. Jyssum I, et al. Among authors: kvien tk. Rheumatology (Oxford). 2023 Sep 29:kead525. doi: 10.1093/rheumatology/kead525. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37773994

6

Improving patient access to biosimilar tumor necrosis factor inhibitors in immune-mediated inflammatory disease: lessons learned from Norway.

Goll GL, Kvien TK. Goll GL, et al. Among authors: kvien tk. Expert Opin Biol Ther. 2023 Jul-Dec;23(12):1203-1209. doi: 10.1080/14712598.2023.2273938. Epub 2023 Dec 28. Expert Opin Biol Ther. 2023. PMID: 37874218

7

Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration.

Gehringer CK, Martin GP, Hyrich KL, Verstappen SMM, Sexton J, Kristianslund EK, Provan SA, Kvien TK, Sergeant JC. Gehringer CK, et al. Among authors: kvien tk. J Clin Epidemiol. 2024 Feb;166:111239. doi: 10.1016/j.jclinepi.2023.111239. Epub 2023 Dec 8. J Clin Epidemiol. 2024. PMID: 38072179 Free article.

8

Generic Tofacitinib-A More Affordable JAK Inhibitor.

Goll GL, Kvien TK. Goll GL, et al. Among authors: kvien tk. Mayo Clin Proc. 2024 Jan;99(1):4-6. doi: 10.1016/j.mayocp.2023.11.014. Mayo Clin Proc. 2024. PMID: 38176834 No abstract available.

9

Biosimilar tocilizumab-better access and lower cost?

Goll GL, Kvien TK. Goll GL, et al. Among authors: kvien tk. Lancet Rheumatol. 2024 Jan;6(1):e6-e8. doi: 10.1016/S2665-9913(23)00268-0. Lancet Rheumatol. 2024. PMID: 38258681 No abstract available.

10

Clinical consequences of infliximab immunogenicity and the effect of proactive therapeutic drug monitoring: exploratory analyses of the randomised, controlled NOR-DRUM trials.

Brun MK, Gehin JE, Bjørlykke KH, Warren DJ, Klaasen RA, Sexton J, Sandanger Ø, Kvien TK, Mørk C, Jahnsen J, Bolstad N, Jørgensen KK, Haavardsholm EA, Goll GL, Syversen SW. Brun MK, et al. Among authors: kvien tk. Lancet Rheumatol. 2024 Apr;6(4):e226-e236. doi: 10.1016/S2665-9913(23)00341-7. Epub 2024 Feb 22. Lancet Rheumatol. 2024. PMID: 38402891 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

672 results

Search Page